ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition ...
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...
endophthalmitis or choroidal neovascularization and no adverse events of special interest; considerably slower lesion growth from baseline in treated eyes versus untreated fellow eyes at 6-month ...
Cataract surgery involves removing the eye's cloudy lens (located at the front of the eye) and replacing it with an artificial, clear lens. Most cataract surgeries are highly successful in restoring ...
Objective: To evaluate systemic inflammatory markers in cases of exogenous endophthalmitis caused by metal foreign bodies after penetrating eye injury and identify risk factors for poor control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results